Effect of Preeclampsia, Magnesium Sulfate Prophylaxis, and Maternal Weight on Labor Induction: A Retrospective Analysis

Background: Our purposes were to determine the effect of preeclampsia, magnesium sulfate prophylaxis, and maternal weight on labor induction in women with preeclampsia and identify risk factors associated with its failure. Methods: Fifty-five preeclamptic women and 176 non-preeclamptic women requiring labor induction over an 18-month period were studied retrospectively. Prostaglandin E2 (dinoprostone) and oxytocin were used for labor induction. Women with rupture of the membranes, spontaneous contraction resulting in cervical change, or an initial cervical examination showing more than 2 cm dilatation and 50% effacement were excluded. Statistics were analyzed with χ2 test, Fisher’s exact test, Student t test, Mann-Whitney U test, and multiple logistic regression. Results: The women with preeclampsia had a significantly higher rate of failed induction than did those without preeclampsia (p = 0.01). However, the women with preeclampsia had a higher mean maternal weight and an increased use of magnesium sulfate, and labor was induced at earlier gestational age than in those without preeclampsia (p < 0.05 for each). Multiple logistic regression showed that the use of magnesium sulfate, higher maternal weight, and unfavorable cervix, but not preeclampsia, were significantly associated with an increased risk of failed induction after correction for known confounding variables. Conclusions: Although the risk of failed induction is increased in preeclamptic women, preeclampsia is not an independent risk factor for failed induction. The use of magnesium sulfate, higher maternal weight, and unfavorable cervix are independent risk factors for failed induction.

[1]  L. Marpeau,et al.  The role of ultrasound and fetal fibronectin in predicting the length of induced labor when the cervix is unfavorable , 2004, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  D. Rouse,et al.  The Association of Maternal Weight With Cesarean Risk, Labor Duration, and Cervical Dilation Rate During Labor Induction , 2003, Obstetrics and gynecology.

[3]  K. Nicolaides,et al.  Preinduction sonographic measurement of cervical length in the prediction of successful induction of labor , 2001, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[4]  S. Blackwell,et al.  Labor induction for the preterm severe pre-eclamptic patient: is it worth the effort? , 2001, The Journal of maternal-fetal medicine.

[5]  H. Odendaal,et al.  Is the prophylactic administration of magnesium sulphate in women with pre‐eclampsia indicated prior to labour? , 2000, BJOG : an international journal of obstetrics and gynaecology.

[6]  B. Griggs The effect of maternal weight on efficacy of intravaginal misoprostol for cervical ripening , 2000 .

[7]  O. Gómez-Marín,et al.  Severe preeclampsia remote from term: labor induction or elective cesarean delivery? , 1998, American journal of obstetrics and gynecology.

[8]  J. Piper,et al.  Induction of Labor in the Nineties: Conquering the Unfavorable Cervix , 1997, Obstetrics and gynecology.

[9]  J. Piper,et al.  Preeclampsia: Is Induction of Labor More Successful? , 1997, Obstetrics and gynecology.

[10]  F. Witter,et al.  Preeclampsia, labor duration and mode of delivery , 1997, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[11]  A. Witlin,et al.  The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. , 1997, American journal of obstetrics and gynecology.

[12]  C. Berg,et al.  Pregnancy‐Related Mortality in the United States, 1987‐1990 , 1996, Obstetrics and gynecology.

[13]  J. Hauth,et al.  Does magnesium sulfate affect the length of labor induction in women with pregnancy-associated hypertension? , 1995, American journal of obstetrics and gynecology.

[14]  B. Sibai,et al.  Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1995, American journal of obstetrics and gynecology.

[15]  K. Lim,et al.  Phenytoin Versus Magnesium Sulfate in Preeclampsia: A Pilot Study , 1993, American journal of perinatology.

[16]  A. Satin,et al.  Factors affecting the dose response to oxytocin for labor stimulation. , 1992, American journal of obstetrics and gynecology.

[17]  D. Wlody,et al.  Hypertension in pregnancy. , 1992, The New England journal of medicine.

[18]  G. Chatellier,et al.  Frequency and perinatal consequences of hypertensive disease of pregnancy. , 1986, Advances in nephrology from the Necker Hospital.

[19]  L. Chesley Hypertensive disorders in pregnancy. , 1985, Journal of nurse-midwifery.

[20]  F. Zuspan,et al.  Factors affecting delivery in eclampsia , 1968 .

[21]  F. Zuspan,et al.  Factors affecting delivery in eclampsia: the condition of the cervix and uterine activity. , 1968, American journal of obstetrics and gynecology.

[22]  E. A. Friedman,et al.  Relation of Prelabor Evaluation to Inducibility and the Course of Labor , 1966, Obstetrics and gynecology.